EichorEICHOR
Study identifier: NCT04104945 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

Condition: Squamous Cell Carcinoma of the Oropharynx  ·  Sponsor: AHS Cancer Control Alberta

PhaseNA
Planned participants32
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Volume and Dose De-Intensified Radiotherapy for p16+ Squamous Cell Carcinoma of the Oropharynx: A Multi-Centre, Single Arm Prospective Cohort Study

This description comes directly from the study's public registry record.

Talk to the study team

Harvey Quon, MD  ·  403-521-3619  ·  harvey.quon@ahs.ca

Kelsey Meyer  ·  Kelsey.Meyer@ahs.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Tom Baker Cancer CentreCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →